Scrambler Therapy with Duloxetine-Based Usual Care vs. Duloxetine-Based Usual Care for Chemotherapy-Induced Peripheral Neuropathy
Pembrolizumab Maintenance After Enfortumab Vedotin/Pembrolizumab Induction in Frontline Metastatic Urothelial Carcinoma (IMPROEV)
Exploring the Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy: A Prospective Study
Dose-Attenuated Chemotherapy in Patients with Lung Cancer and Age >/= 70 and/or Comorbidities
The Gene Fixer
Dana-Farber Researchers Join Global Cancer Grand Challenges Team Taking on the Dark Proteome
Dana-Farber Research Uncovers Approach to Activating the Immune System Against Metastatic Breast Cancer
Fox Chase Cancer Center Celebrates Innovation, Sustained Growth, and Upward Momentum
Researcher Gains Insight into Rare Genetic Diseases
The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer
Delivering Big Ideas from ASH 2025
Fellowship Training That Goes Where You Go
Dana-Farber, Gustave Roussy to Host Fifth Transatlantic Exchange in Oncology Focused on Cancer Drug Innovation
Fox Chase Fellows Shape the World of Cancer Care
Making Breakthroughs in ALL From Youth to Adulthood
Showing 76 - 90 of 1098 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...74 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account